Stay updated on Rapastinel Long-term Safety in Major Depressive Disorder Clinical Trial

Sign up to get notified when there's something new on the Rapastinel Long-term Safety in Major Depressive Disorder Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Rapastinel Long-term Safety in Major Depressive Disorder Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The study record page now shows a 403 Forbidden message with a minimal header and a Home link, indicating restricted access rather than changes to the study details.
    Difference
    16%
    Check dated 2026-09-24T19:20:04.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.7.0, replacing the previous v3.6.6. This indicates a site-wide update rather than a modification to the study content.
    Difference
    0.0%
    Check dated 2026-09-17T20:40:37.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    Revision: v3.6.6 appears, replacing v3.6.5; this denotes a page version update rather than substantive content changes to the study details.
    Difference
    0.0%
    Check dated 2026-09-03T16:56:02.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The study details page updated to revision v3.6.5. Sponsor attribution and some helper-link sections were removed, changing how the sponsor information and navigation are presented.
    Difference
    0.1%
    Check dated 2026-08-13T11:19:58.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    New sections More Information and Helpful Links Provided by Naurex, Inc, an affiliate of Allergan plc have been added, and the revision notice was updated from v3.6.3 to v3.6.4.
    Difference
    0.1%
    Check dated 2026-07-23T09:14:30.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Removed sponsor attribution and footer help sections from the study page. This includes the Naurex, Inc, an affiliate of Allergan plc sponsor line and the 'More Information' and 'Helpful Links Provided by' areas.
    Difference
    0.1%
    Check dated 2026-07-16T08:50:32.000Z thumbnail image

Stay in the know with updates to Rapastinel Long-term Safety in Major Depressive Disorder Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Rapastinel Long-term Safety in Major Depressive Disorder Clinical Trial page.